Lisa Gray

TL;DR: Management of patients with suspected deep-vein thrombosis based on clinical probability and ultrasound of the proximal deep veins is safe and feasible and the need for serial ultrasound testing is reduced and the rate of false-negative or false-positive ultrasound studies is reduced.

TL;DR: Outpatient management of pulmonary embolism is feasible and safe for the majority of patients according to a prospective cohort study of eligible patients using dalteparin for a minimum of five days and warfarin for 3 months.

TL;DR: Tinzaparin and dalteparin are safe and effective for the outpatient treatment of DVT or PE and the finding of no differences between the LMWHs based on major clinical end points means that practical issues can be the deciding factor on which drug to use.

TL;DR: Management of hospitalized patients with suspected deep-vein thrombosis based on clinical probability and ultrasound of the proximal deep veins is safe and feasible.

TL;DR: In this paper, a prospective cohort study was performed in the emergency departments of two tertiary care institutions involving 344 patients with suspected deep vein thrombosis (DVT) and the authors evaluated the accuracy of an explicit clinical model for the diagnosis of DVT when applied by emergency department physicians and to assess the safety and feasibility of a management strategy based on the clinical pretest probability for patients presenting to the emergency department with suspected DVT outside of regular hospital staff work hours.